Farhat, Luis C. http://orcid.org/0000-0002-3147-8344
Flores, José M.
Behling, Emily http://orcid.org/0000-0001-6060-447X
Avila-Quintero, Victor J. http://orcid.org/0000-0001-5699-9819
Lombroso, Adam
Cortese, Samuele
Polanczyk, Guilherme V.
Bloch, Michael H. http://orcid.org/0000-0003-0352-4080
Article History
Received: 14 June 2021
Accepted: 12 November 2021
First Online: 14 January 2022
Competing interests
: The authors report no underlying conflicts of interest. Dr. Farhat receives scholarship stipend from #2021/08540-0, São Paulo Research Foundation (FAPESP). Dr. Flores received salary support from T32MH018268 (NIMH). Dr. Cortese declares honoraria and reimbursement for travel and accommodation expenses for lectures from the following non-profit associations: Association for Child and Adolescent Central Health (ACAMH), Canadian ADHD Alliance Resource (CADDRA), British Association of Pharmacology (BAP), and from Healthcare Convention for educational activity on ADHD. Dr. Polanczyk has served as a consultant/speaker to Shire/Takeda, Ache, Novo Nordisk and Medice and has received royalties from Editora Manole. Dr. Polanczyk receives research support from Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) (grant 16/22455-8). Dr. Bloch receives contracted research support from Therapix Biosciences, Neurocrine Biosciences, Janssen Pharmaceuticals and Biohaven Pharmaceuticals, but none provided support for the current manuscript. Dr. Bloch also receives additional research support from NIH. The other authors report no financial relationships with commercial interests.